Alginate-Based Carriers Loaded with Mulberry (Morus alba L.) Leaf Extract: A Promising Strategy for Prolonging 1-Deoxynojirimicyn (DNJ) Systemic Activity for the Nutraceutical Management of Hyperglycemic Conditions

Lucia Marchetti,Eleonora Truzzi,Maria Cecilia Rossi,Stefania Benvenuti,Silvia Cappellozza,Alessio Saviane,Luca Bogataj,Cristina Siligardi,Davide Bertelli
DOI: https://doi.org/10.3390/molecules29040797
IF: 4.6
2024-02-09
Molecules
Abstract:The iminosugar 1-deoxynojirimicyn (DNJ) contained in mulberry leaves has displayed systemic beneficial effects against disorders of carbohydrate metabolism. Nevertheless, its effect is impaired by the short half-life. Alginate-based carriers were developed to encapsulate a DNJ-rich mulberry extract: Ca-alginate beads, obtained by external gelation, and spray-dried alginate microparticles (SDMs). Mean size and distribution, morphology, drug loading, encapsulation efficiency, experimental yield, and release characteristics were determined for the two formulations. Ca-alginate beads and SDMs exhibited an encapsulation efficiency of about 54% and 98%, respectively, and a DNJ loading in the range of 0.43–0.63 μg/mg. The in vitro release study demonstrated the carriers' capability in controlling the DNJ release in acid and basic conditions (<50% in 5 h), due to electrostatic interactions, which were demonstrated by 1H-NMR relaxometry studies. Thus, alginate-based particles proved to be promising strategies for producing food supplements containing mulberry leaf extracts for the management of hyperglycemic state.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?
### What problem does this paper attempt to solve? This paper primarily addresses the following issues: **1. Background and Objectives:** - **Diabetes Management:** Diabetes (especially type 2 diabetes) is a global health issue with an increasing incidence rate. Mulberry leaf extract, which contains various beneficial components such as polyphenols and 1-deoxynojirimycin (DNJ), has been shown to have potential therapeutic effects on diabetes and its complications. - **Limitations of DNJ:** Although DNJ has shown good effects in controlling blood sugar, its bioavailability is limited by its short half-life, necessitating frequent administration. **2. Research Objectives:** - **Prolonging DNJ Activity:** Develop an alginate-based delivery system to encapsulate DNJ-rich mulberry leaf extract, thereby extending the active time of DNJ in the body. - **Improving Bioavailability:** Design carriers that can effectively control the release of DNJ, allowing it to continuously act in the intestines and eventually enter the bloodstream to exert systemic effects. **3. Specific Methods:** - **Two Delivery Systems:** The paper introduces two different delivery systems: - **Calcium Alginate Beads (Ca-alginate beads):** Millimeter-sized particles prepared by external gelation. - **Spray-Dried Alginate Microparticles (SDMs):** Micron-sized particles prepared by spray-drying technology. - **Experimental Results:** Detailed analysis of the physicochemical properties, encapsulation efficiency, and in vitro release characteristics of these two carriers, and confirmation of charge interactions through nuclear magnetic resonance (NMR) studies. In summary, this paper aims to develop a novel delivery system to enhance the bioavailability and duration of DNJ in mulberry leaf extract for the treatment of hyperglycemic conditions. This strategy holds promise for providing more effective functional food supplements for diabetic patients.